0.5522

7.20% 0.0371

After Hours: .55 -0.00218 -0.40%

China Pharma Holdings Inc. (CPHI)

Overview News Price History Discussions Forecast Stock Split

China Pharma Holdings Inc. stock is traded at $0.5522, with a volume of 15,344. It is up +7.20% in the last 24 hours and down -12.35% over the past month. China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.

Previous Close:

$0.5151

Open:

$0.515

24h Volume:

15,344

Relative Volume:

0.35

Market Cap:

$22.38M

Revenue:

$4.14M

Net Income/Loss:

$-3.19M

P/E Ratio:

-0.7391

EPS:

-0.7471

Net Cash Flow:

$11,000

1W Performance:

-2.08%

1M Performance:

-12.35%

6M Performance:

-63.29%

1Y Performance:

-70.78%

1-Day Range:

$0.515

$0.5699

1-Week Range:

$0.50

$0.5799

52-Week Range:

$0.50

$2.5977

China Pharma Holdings Inc. Stock (CPHI) Company Profile

Name

China Pharma Holdings Inc.

Sector

Healthcare (1106)

Industry

Drug Manufacturers - Specialty & Generic (84)

Phone

86 898 6681 1730

Address

No. 17, Jinpan Road, Second Floor, Haikou

Employee

276

Twitter

Next Earnings Date

2026-05-13

Latest SEC Filings

CPHI's Discussions on Twitter

Compare CPHI vs TAK, ZTS, TEVA, HLN, UTHR

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CPHI China Pharma Holdings Inc.	0.5522	20.87M	4.14M	-3.19M	11,000	-0.7471
TAK Takeda Pharmaceutical Co Adr	16.55	52.32B	29.85B	776.90M	4.35B	0.2408
ZTS Zoetis Inc	112.54	47.38B	9.47B	2.67B	2.28B	6.0218
TEVA Teva Pharmaceutical Industries Ltd Adr	35.86	41.16B	17.53B	1.58B	444.18M	1.3457
HLN Haleon Plc Adr	9.17	41.02B	14.54B	2.22B	2.58B	0.4871
UTHR United Therapeutics Corp	572.20	24.67B	3.18B	1.33B	1.04B	27.90

China Pharma Holdings Inc. Stock (CPHI) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-08-10	Initiated	Rodman & Renshaw	Mkt Outperform

China Pharma Holdings Inc. Stock (CPHI) Latest News

May 01, 2026

China NT Pharma Group Quarterly Update on Action Plans for Disclaimer of Opinion Resolution and AI Health Business Transformation 1 - Minichart

May 01, 2026

Apr 30, 2026

Chinese firm Livzon secures control of Vietnam’s pharma giant Imexpharm in $228 mln deal - Theinvestor

Apr 30, 2026

Apr 29, 2026

Why Seagate Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket - Benzinga

Apr 29, 2026

Apr 27, 2026

Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by China Universal Asset Management Co. Ltd. - MarketBeat

Apr 24, 2026

Apr 16, 2026

China Pharma (CPHI) Stock Dividend Analysis (+1.54%) 2026-04-16Price Action - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 16, 2026

Apr 14, 2026